Dec M, Arasiewicz H
Postepy Dermatol Alergol. 2024; 41(3):251-261.
PMID: 39027696
PMC: 11253314.
DOI: 10.5114/ada.2024.141114.
Fasolino G, Awada G, Moschetta L, Koulalis J, Neyns B, Verhelst B
J Clin Med. 2023; 12(3).
PMID: 36769861
PMC: 9918243.
DOI: 10.3390/jcm12031214.
Heng J, Kim J, Jones D, Stoessel K, Weiss S, Sznol M
BMJ Open Ophthalmol. 2022; 7(1):e000889.
PMID: 35047671
PMC: 8724805.
DOI: 10.1136/bmjophth-2021-000889.
Gameiro Filho A, Sturzeneker G, Rodriguez E, Maia A, Morales M, Belfort R
Int J Retina Vitreous. 2021; 7(1):27.
PMID: 33795031
PMC: 8017785.
DOI: 10.1186/s40942-021-00300-0.
Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A
Indian J Ophthalmol. 2020; 68(9):1829-1837.
PMID: 32823399
PMC: 7690499.
DOI: 10.4103/ijo.IJO_786_20.
Nonantibestrophin Anti-RPE Antibodies in Paraneoplastic Exudative Polymorphous Vitelliform Maculopathy.
Dalvin L, Johnson A, Pulido J, Dhaliwal R, Marmorstein A
Transl Vis Sci Technol. 2015; 4(3):2.
PMID: 26046004
PMC: 4451878.
DOI: 10.1167/tvst.4.3.2.
Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy.
Wang Y, Abu-Asab M, Li W, Aronow M, Singh A, Chan C
BMC Ophthalmol. 2012; 12:56.
PMID: 23148706
PMC: 3514129.
DOI: 10.1186/1471-2415-12-56.
Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.
Aronow M, Adamus G, Abu-Asab M, Wang Y, Chan C, Zakov Z
Surv Ophthalmol. 2012; 57(6):558-64.
PMID: 22784677
PMC: 3470815.
DOI: 10.1016/j.survophthal.2012.02.004.
Melanoma-associated retinopathy associated with intranasal melanoma.
Machida S, Ohguro H, Tateda M, Sato H, Kurosaka D
Doc Ophthalmol. 2011; 122(3):191-7.
PMID: 21537930
DOI: 10.1007/s10633-011-9272-3.
Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y, Jia L, He S, Hurley M, Leys M, Jayasundera T
Arch Ophthalmol. 2009; 127(12):1572-80.
PMID: 20008709
PMC: 4618318.
DOI: 10.1001/archophthalmol.2009.311.
